Press Room - Specialised Therapeutics - Page 3

The following news clip appeared on National Nine News. Click to view.  

PHARMA IN FOCUS By Megan Brodie 17 May 2019 Drugs to be Tracked End-to-End Local pharma Specialised Therapeutics Australia (STA) has launched a tracking system that will enable real time monitoring of its drug products as they move through the supply chain, while also making the practice of vial sharing more difficult. The company has

PHARMA IN FOCUS By Megan Brodie 14 May 2019 PBAC System Labelled ‘Broken’ Australia’s reimbursement process for listing new drugs is broken and Australia is now on the precipice of missing out on new drugs, Specialised Therapeutics Australia CEO Carlo Montagner has warned. Companies spend millions of dollars and take years to get a new

Weekend Australian By Sarah-Jane Tasker 11 May 2019 Speed Up Cancer Funding, ALP Told The head of Australian drug company Specialised Therapeutics, Carlo Montagner, has warned that Bill Shorten’s cancer policy will not hit its target unless he overhauls the process to reimburse lifesaving treatments and puts a time frame on listing recommended drugs. Mr

AUSTRALIAN PHARMACIST 1 May 2019 Medicines Update: Nerlynx – Puma Biotechnology A new medicine shown to significantly reduce the risk of cancer recurrence or death in an aggressive form of breast cancer has been approved by the TGA for use in Australian patients. Nerlynx (neratinib) is an oral medication taken for 12 months by women

3AW 19 March 2019 Interview with Dr Richard de Boer, Oncologist, Peter MacCallum Cancer Centre Interview with Dr Richard de Boer, oncologist, Peter MacCallum Cancer Centre. Mitchell says it has been discovered a drug is effective in reducing the chance of relapse of breast cancer. De Boer explains this drug has been approved by the

HERALD SUN (MELBOURNE) By Aleks Devic 19 March 2019 Breast cancer hope: Regulator green-lights treatment A NEW breast cancer wonder drug has been approved for use in Australia from today. Women diagnosed with the aggressive HER2+ breast cancer have a one in four chance of relapse, even after surgery and chemotherapy. But test data has

The West Australian (Perth) 19 March 2019 Cancer Drug Nod A new breast cancer wonder drug has been approved for use in Australia from today. Women diagnosed with the aggressive HER2+ breast cancer have a one in four chance of relapse, even after surgery and chemotherapy. Nerlynx reduces the five-year risk of death or recurrence

Channel 9 4 June 2018 Interview with Dr Penny Adams, Medical Expert Interview with Dr Penny Adams, Medical Expert. There is a medical breakthrough for women with the most common form of early-stage breast cancer, with new research revealing that genetic testing could help them skip chemotherapy without affecting their chances of beating the disease.

The Australian 4 June 2018 Breast Cancer Patients Can Skip Chemo: Study CHICAGO: About 70 per cent of women with early-stage breast cancer and an intermediate risk of cancer recurrence can safely skip chemotherapy after their tumours have been removed, US researchers say. “This is a major finding,” said Larry Norton, a breast cancer expert